Noom Microdose GLP-1 Protocol Noom Meds GLP-1 microdosing program uses compounded semaglutide starting at 0.1-0.2mg combined with behavioral coaching
This does not necessarily mean abandoning tirzepatide
Quite on the contrary, some papers suggested SGLT-2 inhibitors as drugs of choice 35
According to research in the American Journal of Clinical Nutrition, adequate protein intake during weight loss preserves lean muscle mass and supports sustained metabolic rate, leading to better long-term outcomes
Common side effects and supportive care Depending on the medication and the dosing schedule, common side effects can include nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, and sometimes heartburn